Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/15/10 → 1/31/13 |
Funding
- Novo Nordisk Pharmaceuticals Inc: $17,451.00
A Mulit-National, Open-Label, Dose Escalation Trial, Evaluating Safety and Pharmacokinetics of Intravenous Doses of NNC 0129-0000-1003 in Patients with Haemophilia A
- Radulescu, Vlad (PI)